SG11201811433TA - Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method - Google Patents
Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test methodInfo
- Publication number
- SG11201811433TA SG11201811433TA SG11201811433TA SG11201811433TA SG11201811433TA SG 11201811433T A SG11201811433T A SG 11201811433TA SG 11201811433T A SG11201811433T A SG 11201811433TA SG 11201811433T A SG11201811433T A SG 11201811433TA SG 11201811433T A SG11201811433T A SG 11201811433TA
- Authority
- SG
- Singapore
- Prior art keywords
- marker
- ovarian cancer
- cancer prognosis
- diagnosis
- prediction
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016121392A JP6143920B1 (ja) | 2016-06-20 | 2016-06-20 | 卵巣がんの予後診断マーカーとしてのｍｍｐ１遺伝子転写産物と検査法 |
| PCT/JP2017/022680 WO2017221927A1 (ja) | 2016-06-20 | 2017-06-20 | 卵巣がんの予後診断マーカーとしてのｍｍｐ１遺伝子転写産物と検査法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201811433TA true SG11201811433TA (en) | 2019-01-30 |
Family
ID=59012109
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201811433TA SG11201811433TA (en) | 2016-06-20 | 2017-06-20 | Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20190316205A1 (de) |
| EP (1) | EP3473729A4 (de) |
| JP (1) | JP6143920B1 (de) |
| CN (1) | CN110023510A (de) |
| AU (1) | AU2017282420A1 (de) |
| CA (1) | CA3067527A1 (de) |
| SG (1) | SG11201811433TA (de) |
| WO (1) | WO2017221927A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112575085A (zh) * | 2020-12-22 | 2021-03-30 | 复旦大学附属华山医院 | 用于肾上腺皮质癌预后的基因表达谱 |
| CN114752673B (zh) * | 2022-04-30 | 2023-07-28 | 重庆大学附属肿瘤医院 | 一种检测isyna1表达水平的试剂在制备卵巢癌干性鉴别试剂中的应用 |
| WO2024009946A1 (ja) * | 2022-07-08 | 2024-01-11 | 国立大学法人東海国立大学機構 | 卵巣癌に対するｐａｒｐ阻害剤の有効性を検査する方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050032063A1 (en) * | 2001-12-03 | 2005-02-10 | Michael Kopreski | Detection of matrix metalloproteinase rna in plasma and serum |
| WO2012115820A2 (en) * | 2011-02-24 | 2012-08-30 | Vermillion, Inc. | Biomarker panels, diagnostic methods and test kits for ovarian cancer |
| CA2847290A1 (en) | 2011-08-30 | 2013-03-07 | Dcb-Usa Llc | Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers |
| WO2014062978A1 (en) * | 2012-10-17 | 2014-04-24 | Cedars-Sinai Medical Center | Molecular signatures of ovarian cancer |
-
2016
- 2016-06-20 JP JP2016121392A patent/JP6143920B1/ja active Active
-
2017
- 2017-06-20 SG SG11201811433TA patent/SG11201811433TA/en unknown
- 2017-06-20 AU AU2017282420A patent/AU2017282420A1/en not_active Abandoned
- 2017-06-20 WO PCT/JP2017/022680 patent/WO2017221927A1/ja unknown
- 2017-06-20 CN CN201780043531.0A patent/CN110023510A/zh active Pending
- 2017-06-20 EP EP17815395.3A patent/EP3473729A4/de not_active Withdrawn
- 2017-06-20 US US16/312,093 patent/US20190316205A1/en not_active Abandoned
- 2017-06-20 CA CA3067527A patent/CA3067527A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2017282420A1 (en) | 2019-02-07 |
| EP3473729A1 (de) | 2019-04-24 |
| CA3067527A1 (en) | 2017-12-28 |
| WO2017221927A1 (ja) | 2017-12-28 |
| US20190316205A1 (en) | 2019-10-17 |
| JP6143920B1 (ja) | 2017-06-07 |
| CN110023510A (zh) | 2019-07-16 |
| EP3473729A4 (de) | 2020-02-26 |
| JP2017225352A (ja) | 2017-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2568608A (en) | Personalized genetic testing | |
| MX2013001042A (es) | Biomarcadores de cancer pancreatico y usos de los mismos. | |
| MX2020004617A (es) | Prediccion de riesgo de evento cardiovascular y usos del mismo. | |
| MX2015016047A (es) | Metodo y sistema para mantener o mejorar el bienestar. | |
| NZ607282A (en) | Method for using gene expression to determine prognosis of prostate cancer | |
| WO2014186761A3 (en) | Methods for determining responsiveness to an anti-cd47 agent | |
| EP4361607A3 (de) | Signalkodierung und -dekodierung in multiplexierten biochemischen assays | |
| MY170164A (en) | Aptamer-based multiplexed assays | |
| IN2014CN01787A (de) | ||
| WO2014065889A3 (en) | Multiplexed method for diagnosing classical hodgkin lymphoma | |
| WO2012096545A3 (ko) | 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도 | |
| EA030186B9 (ru) | Способ проведения количественных анализов | |
| WO2008128043A3 (en) | Diagnostic and prognostic methods for renal cell carcinoma | |
| WO2015095862A3 (en) | Microrna biomarkers for ovarian cancer | |
| SG11201811433TA (en) | Mmp1 gene transcript for use as marker for diagnosis of ovarian cancer prognosis, and test method | |
| BR112022011676A2 (pt) | Kit para detectar um analito de interesse em uma pluralidade de amostras líquidas biológicas, método para detectá-lo e /ou quantificá-lo e cartucho para realizar tal método | |
| WO2018097614A3 (ko) | 유방암 환자의 화학치료 유용성 예측 방법 | |
| MX2015013415A (es) | Metodo y sistema para analizar especímenes biológicos mediante formación de imágenes espectrales. | |
| WO2014053996A3 (en) | Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs | |
| WO2015091575A3 (en) | Different levels in blood cell samples of emt-markers for the diagnosis of cancer, in particular of colorectal (crc) and pancreatic (pc) cancer | |
| MX369610B (es) | Metodos, dispositivos y sistemas para analisis de muestras. | |
| WO2012050365A3 (ko) | 교모세포종의 진단 또는 예후 예측용 바이오 마커 및 그 용도 | |
| WO2019066572A3 (en) | Method and device for analyzing target analyte in sample | |
| WO2011137388A3 (en) | Identification and use of biomarkers for detection and quantification of the level of radiation exposure in a biological sample | |
| GB2542576A (en) | Method and kit of detecting the absence of micro-oranisms |